Edgestream Partners L.P. Sells 8,139 Shares of Balchem Co. (NASDAQ:BCPC)

Edgestream Partners L.P. lowered its holdings in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 47.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 9,109 shares of the basic materials company's stock after selling 8,139 shares during the period. Edgestream Partners L.P.'s holdings in Balchem were worth $1,603,000 as of its most recent filing with the SEC.

A number of other large investors have also added to or reduced their stakes in the company. William Blair Investment Management LLC lifted its position in Balchem by 8.4% during the 2nd quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company's stock valued at $35,998,000 after acquiring an additional 18,104 shares during the period. Oppenheimer Asset Management Inc. lifted its holdings in shares of Balchem by 22.1% in the second quarter. Oppenheimer Asset Management Inc. now owns 20,582 shares of the basic materials company's stock worth $3,169,000 after buying an additional 3,732 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Balchem by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company's stock worth $63,707,000 after buying an additional 7,562 shares in the last quarter. Fiera Capital Corp purchased a new stake in Balchem during the third quarter valued at $4,201,000. Finally, Envestnet Asset Management Inc. raised its stake in shares of Balchem by 9.9% in the second quarter. Envestnet Asset Management Inc. now owns 114,253 shares of the basic materials company's stock valued at $17,589,000 after acquiring an additional 10,285 shares during the period. Institutional investors own 87.91% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on BCPC. HC Wainwright increased their target price on shares of Balchem from $185.00 to $190.00 and gave the stock a "buy" rating in a report on Monday, November 4th. StockNews.com upgraded Balchem from a "hold" rating to a "buy" rating in a report on Monday, October 28th.

Balchem Price Performance

Shares of BCPC traded up $1.59 during trading hours on Wednesday, reaching $179.58. 87,900 shares of the company traded hands, compared to its average volume of 110,075. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $5.84 billion, a PE ratio of 47.85, a price-to-earnings-growth ratio of 5.41 and a beta of 0.67. The stock has a fifty day simple moving average of $174.61 and a 200 day simple moving average of $167.93. Balchem Co. has a fifty-two week low of $125.23 and a fifty-two week high of $186.03.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.